To view this email as a web page, click here.

Ovarian Suppression Combined with Tamoxifen May Help Premenopausal Patients

A phase III study found that adding 2 years of ovarian function suppression to tamoxifen extended disease-free survival in certain patients with hormone receptor–positive breast cancer.

Link Found Between Atrial Fibrillation, Chemotherapy Treatment for Early-Stage Breast Cancer

A recent study found that women with early-stage breast cancer experienced atrial fibrillation in the first and fifth years following diagnosis.

In Case You Missed It

First-Line Treatment in Metastatic Colorectal Cancer?

Liquid Test, Solid Answers

FoundationOne^®Liquid can deliver reliable answers faster than tissue testing by analyzing 70 genes and reporting on microsatellite instability high (MSI-H) status from a simple blood draw.

Read more.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.